Sickle Cell Disease |
Decreased bulk contraction force |
(103) |
Asthma |
Decreased bulk contraction force |
(104) |
Lupus |
Decreased bulk contraction force |
(105) |
Acute ischemic stroke |
Decreased bulk contraction force |
(106) |
Covid-19 |
Decreased bulk contraction force |
(114) |
Trauma |
Decreased aggregate and bulk contraction force |
(99) (107) |
Thromboangiitis obliterans |
Increased bulk contraction force |
(109) |
Polycythemia Vera |
Increased bulk contraction force |
(110) |
Severe coronary artery disease |
Increased bulk contraction force |
(111) |
Chest pain associated coronary artery disease |
Increased bulk contraction force and increased clot elastic modulus |
(112) |
May Hegglin Disorder |
Decreased single platelet contractile force |
(74, 113) |
Wiskot Aldrich Syndrome |
Decreased single platelet contractile force |
(74) |
Symptomatic Bleeding |
Decreased single platelet contraction force |
(74) |
type 2B von Willebrand’s Disease |
Enhanced mechanical activation of GP1b leading to platelet clearance |
(49) |
Glanzmann’s thrombasthenia |
Impaired platelet adhesion to fibrinogen |
(67, 68) |
Bernard-Soulier syndrome |
Impaired adhesion to vWF |
(47) |
GPVI deficiency |
Impaired platelet response to collagen |
(115) |
α2β1 deficiency |
Impaired platelet response to collagen |
(83) |